Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propiverine ER 45 mg versus IR 15 mg in neurogenic detrusor overactivity
2012-003159-12Phase 3Completed
- Sponsor
- APOGEPHA
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propiverine in detrusor hyperreflexia (DH), sponsored by APOGEPHA. Started Aug 2012; status: completed.
02
Drugs
propiverine
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on 2012-003159-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003159-12.